Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence of hyaluronan in human tears and secretions of conjunctival cultures.

Literature DB >> 7958290

Evidence of hyaluronan in human tears and secretions of conjunctival cultures.

M Frescura¹, M Berry, A Corfield, S Carrington, D L Easty.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Hyaluronic Acid

Year: 1994 PMID： 7958290 DOI： 10.1042/bst022228s

Source DB: PubMed Journal: Biochem Soc Trans ISSN： 0300-5127 Impact factor: 5.407

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Hyaluronan production and hyaluronan synthase expression in three human conjunctiva-derived cell strains.

Authors: Yoshiko Kashiwagi; Koichi Nishitsuka; Teiko Yamamoto; Hiroshi Takamura; Hidetoshi Yamashita
Journal: Jpn J Ophthalmol Date: 2011-08-24 Impact factor: 2.447

2. Iodide protection from UVB irradiation-induced degradation of hyaluronate and against UVB-damage of human conjunctival fibroblasts.

Authors: Otto Schmut; Jutta Horwath-Winter; Gebhard Rieger; Rudolf Winkler; Gabriele Trummer; Helga Spitzenberger; Christa Wachswender
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2003-12-16 Impact factor: 3.117

3. A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome.

Authors: Juan Carlos Pinto-Bonilla; Alberto Del Olmo-Jimeno; Fernando Llovet-Osuna; Emiliano Hernández-Galilea
Journal: Ther Clin Risk Manag Date: 2015-04-13 Impact factor: 2.423

4. Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.

Authors: Yuri S Astakhov; Sergei Y Astakhov; Alla B Lisochkina
Journal: Clin Ophthalmol Date: 2013-12-09

9. Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water.

Authors: Costanza Tredici; Romina Fasciani; Antonio Villano; Gloria Gambini; Aldo Caporossi
Journal: Eur J Ophthalmol Date: 2020-02-16 Impact factor: 2.597

9 in total

Evidence of hyaluronan in human tears and secretions of conjunctival cultures.

1. Hyaluronan production and hyaluronan synthase expression in three human conjunctiva-derived cell strains.

2. Iodide protection from UVB irradiation-induced degradation of hyaluronate and against UVB-damage of human conjunctival fibroblasts.

3. A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome.

4. Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.

5. Increased concentration of hyaluronan in tears after soaking contact lenses in Biotrue multipurpose solution.

6. Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study.

Review 7. Why Chain Length of Hyaluronan in Eye Drops Matters.

8. Reducing dropout of contact lens wear with Biotrue multipurpose solution.

9. Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water.